drugset / Trial / NCT04828174
Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies
Phase 1
Suspended
9 enrolled
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of CAR T cell treatment targeting TRBC1 in patients with relapsed or refractory TRBC1 positive T-cell hematological maliganacies
Timeline
- Start
- 2021-03-31
- Primary completion
- 2023-11-26
- Completion
- 2023-11-26
Outcome
Outcome not reported
Stopped (Enrollment): “The trial was suspended due to the inability to enroll qualified participants”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | anti-TRBC1 CAR-T cell therapy | Cell therapy | — | — |